IntraBio’s Aqneursa Becomes Second Approved NPC Therapy In Four Days

 
• By Joseph Haas
  
Niemann-Pick type C
IntraBio's Aqneursa becomes the second approved therapy for Niemann-Pick disease type C • Source: Shutterstock

More from New Products

More from Scrip